Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biomerica (BMRA) Accounts Payables (2016 - 2026)

Biomerica's Accounts Payables history spans 16 years, with the latest figure at $730000.0 for Q1 2026.

  • Quarterly results put Accounts Payables at $730000.0 for Q1 2026, up 15.51% from a year ago — trailing twelve months through Feb 2026 was $730000.0 (up 15.51% YoY), and the annual figure for FY2025 was $672000.0, up 20.0%.
  • Accounts Payables for Q1 2026 was $730000.0 at Biomerica, down from $740000.0 in the prior quarter.
  • In the past five years, Accounts Payables ranged from a high of $2.6 million in Q1 2022 to a low of $344000.0 in Q2 2023.
  • The 5-year median for Accounts Payables is $713000.0 (2023), against an average of $822728.4.
  • The sharpest move saw Accounts Payables surged 245.02% in 2022, then tumbled 85.16% in 2023.
  • Year by year, Accounts Payables stood at $670074.0 in 2022, then increased by 16.85% to $783000.0 in 2023, then grew by 8.3% to $848000.0 in 2024, then fell by 12.74% to $740000.0 in 2025, then dropped by 1.35% to $730000.0 in 2026.
  • According to Business Quant data, Accounts Payables over the past three periods came in at $730000.0, $740000.0, and $681000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.